Skip to main content

Month: August 2023

Global Feed Enzymes Market Size to Reach USD 2.89 Billion 2030 | Emergen Research

Provision of feed cost-efficiency is a significant factor driving global feed enzymes market revenue growth Vancouver, Aug. 17, 2023 (GLOBE NEWSWIRE) — The latest analysis conducted by Emergen Research anticipates that the global feed enzymes market will achieve a size of approximately USD 2.89 Billion by the year 2030. This growth is projected to be sustained, with a consistent Compound Annual Growth Rate (CAGR) of 8.1% in terms of revenue. The driving force behind this steady market expansion lies in the capacity of feed enzymes to enhance feed cost-efficiency. The utilization of feed enzymes presents a cost-effective strategy across multiple dimensions. By employing enzyme supplements, a practical method is employed to enhance the overall well-being of livestock. This is achieved by bolstering the absorption rate of supplements...

Continue reading

Semantix Announces 2Q 2023 Financial Results

Proprietary SaaS Revenue and Gross Profit increases 47% and 51% in 2Q23 yoy respectively SÃO PAULO, Brazil, Aug. 17, 2023 (GLOBE NEWSWIRE) — Semantix, Inc. (NASDAQ: STIX), a leading Latin American enterprise AI platform and applications provider, today announced its financial results for the quarter ended June 30, 2023. “Second Quarter results reflect ongoing momentum in margin accretive proprietary SaaS revenue, which has been primarily fueled by the adoption of our cutting-edge AI applications. As an AI centric company, we have always been at the forefront of innovation, and we are thrilled to witness our customers’ increasing realization of how AI can solve their challenges,” said Leonardo Santos, CEO and Founder of Semantix. “With the benefits of AI becoming more tangible, we are leveraging our product positioning and...

Continue reading

Nanox Announces Second Quarter of 2023 Financial Results and Provides Business Update

Reports progress towards global supply chain development Ended the second quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of $80.3 million Management to host conference call and webcast Thursday, August 17, 2023 at 8:30 AM ET NEVE ILAN, Israel, Aug. 17, 2023 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2023 and provided a business update. Second Quarter 2023 Highlights and Recent Developments:  ●   On April 28, 2023, the Company received 510(k) clearance from the U.S. Food and Drug Administration (the “FDA”) to market the Nanox.ARC (including the Nanox.CLOUD) as a stationary ‎X-ray ‎system ‎intended to produce tomographic images of the human...

Continue reading

Rush Street Interactive Selected by Delaware Lottery as Its Vendor for Online Gaming Operations

CHICAGO, Aug. 17, 2023 (GLOBE NEWSWIRE) — Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports betting company in the United States, today announced that it has been selected by the Delaware State Lottery as its vendor for the state’s online gaming business. RSI will provide state-of-the-art online gaming in Delaware for an initial term of 5 years, renewable for additional 1-year terms for an additional 5 years pending regulatory approvals. “We are honored to be selected by the Delaware State Lottery selection committee to provide online gaming operations in the First State,” said Richard Schwartz, CEO of RSI. “This partnership is yet another significant milestone for RSI, as the confidence of a state-backed organization, such as the Delaware Lottery, further validates the trust that lottery officials...

Continue reading

Nubeva Files U.S. Patent for AI-Powered Decryptor Builder to Further Enhance Proven Ransomware Reversal Offering

SAN JOSE, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) — Nubeva Technologies (TSX-V: NBVA), a cybersecurity company specializing in ransomware decryption, has filed a U.S. patent application for an AI-powered decryptor builder, a groundbreaking enhancement to its third-party validated Ransomware Reversal offering. This innovative development will enable Nubeva to accelerate the process of delivering customized decryptors for customers affected by new ransomware variants, further reducing recovery times for ransomed organizations. “When hit by ransomware, the top priority is getting systems back online. That’s where Nubeva’s primary value lies; we specialize in decrypting ransomware by capturing encryption keys, which is the hardest part of the process and something we’ve mastered,” said Steve Perkins, CMO...

Continue reading

Printing Leader Inks New Deal to Power Online Growth for Franchises with TrusPresence

WOBURN, Mass., Aug. 17, 2023 (GLOBE NEWSWIRE) — Today, Bridgeline Digital, Inc. (NASDAQ: BLIN) a marketing software service provider, announced that a leading US printing and marketing company has renewed its enterprise-level agreement with Bridgeline’s online franchise solution, TruPresence. The printing powerhouse has expanded its enterprise contract to $94k over a 12-month period to continue to leverage the TruPresence platform to drive its online reach across its 300+ local business centers. The company has been in business for over 50 years and was one of the first US printers to expand its footprint internationally. With the help of the TruPresence platform, the business is able to target their business to local markets and provide tailored messaging, products and services at the franchisee level.. TruPresence helps...

Continue reading

Nemaura Medical Announces SFDA Approval of sugarBEAT®

Loughborough, England, Aug. 17, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today announced SFDA (Saudi Food and Drug Authority) approval of sugarBEAT®, its non-invasive wearable glucose sensor. The news comes following over a year of liaisons with the SFDA through TPMENA, the Company’s licensee in the Middle East, and is seen as a major breakthrough in product commercialisation in the largest territory in the Middle East, and a region with one of the world’s highest diabetes prevalence rates. In 2021, the Economist Intelligence Unit published a report titled ‘Telemedicine and Diabetes Care in Saudi Arabia and the...

Continue reading

Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors

CARLSBAD, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announced today it is partnering with Translational Drug Development (TD2) as the contract research organization (CRO) to conduct the Phase 1 clinical development of lead drug candidate QN-302. Qualigen received US FDA IND clearance earlier this month to initiate a Phase 1 clinical trial of QN-302, a small molecule G-Quadruplex (G4)-selective transcription inhibitor, for the treatment of advanced or metastatic solid tumors. Tariq Arshad, M.D., M.B.A., Chief Medical Officer, stated: “I am delighted that the FDA has cleared QN-302 to enter the clinic for the proposed Phase 1 clinical trial in...

Continue reading

ToughBuilt Industries to Report Second Quarter 2023 Financial Results on August 22, 2023

Earnings Conference Call to be held at 5:00 p.m. ET LAKE FOREST, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt”) (NASDAQ: TBLT; TBLTW), today reports that it will hold an earnings call to discuss the Company’s 2023 Second quarter financial and operating results on Tuesday August 22, 2023 at 5:00pm ET. Michael Panosian, Chief Executive Officer, and Martin Galstyan, Chief Financial Officer, will host the conference call to review the Company’s financial and operating results. To attend the conference call, please dial one of the teleconference numbers below or follow the audio webcast here. Attendees are encouraged to dial in to the conference call at least five minutes prior to the start time. U.S. TOLL-FREE: 1-877-407-9716INTERNATIONAL: 1-201-493-6779 To listen to a replay of the...

Continue reading

Creative Realities Announces Pricing of $6 Million Public Offering of Common Stock

LOUISVILLE, Ky., Aug. 17, 2023 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX, CREXW), a leading provider of digital signage solutions, today announced the pricing of its previously announced “reasonable best efforts” public offering of 3,000,000 shares of common stock at a purchase price of $2.00 per share for aggregate gross proceeds of approximately $6 million, before deducting placement agent fees and other offering expenses. The closing of the offering is expected to occur on or about August 21, 2023, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from this offering for general corporate purposes, which may include repayment of principal on the Company’s indebtedness, capital...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.